Becker's Healthcare January 8, 2024
Ozempic is facing increased competition from compounded versions and rival drugmakers, while potential side effects, including suicidal thoughts and hair loss, have spurred investigations into it and similar drugs.
Four recent updates on the Type 2 diabetes drug:
1. Compounded solutions
As the FDA investigates compounded versions of Ozempic, its maker Novo Nordisk filed more lawsuits against spas, clinics and compounding pharmacies for allegedly selling unapproved copycats. The FDA warned clinicians Dec. 21 about possible infection risks tied with these solutions, reasoning the agency can’t confirm the drugs’ sterility.
The FDA said it has received five reports of adverse events from the counterfeit products, which were not severe and similar to Ozempic’s side effects.
Between 2021 and 2023,...
Today's Sponsors
Today's Sponsor